- 全部删除
- 您的购物车当前为空
FSCPX是一种针对A1 腺苷受体(A1AR)的强效、选择性不可逆拮抗剂,显示出低纳摩尔级的结合效能。此外,FSCPX能有效降低豚鼠心房中的间质腺苷水平,进而改变核苷转运抑制剂NBTI的效果。
为众多的药物研发团队赋能,
让新药发现更简单!
FSCPX是一种针对A1 腺苷受体(A1AR)的强效、选择性不可逆拮抗剂,显示出低纳摩尔级的结合效能。此外,FSCPX能有效降低豚鼠心房中的间质腺苷水平,进而改变核苷转运抑制剂NBTI的效果。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 783 | In stock | |
5 mg | ¥ 2,000 | In stock | |
10 mg | ¥ 2,800 | In stock | |
25 mg | ¥ 4,160 | In stock | |
50 mg | ¥ 5,580 | In stock | |
100 mg | ¥ 7,420 | In stock | |
200 mg | ¥ 10,000 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 553 | In stock |
FSCPX 相关产品
产品描述 | FSCPX is a potent and selective irreversible antagonist of the A1 adenosine receptor (A1AR), exhibiting low nanomolar binding potency. Additionally, FSCPX can effectively decrease the interstitial adenosine level in the guinea pig atrium, thereby modifying the effect of NBTI, a nucleoside transport inhibitor. |
靶点活性 | DDT1 MF2 cells:11.8±3.2 nM |
体外活性 | FSCPX(2-20 μM;48小时)在不影响HSP70 mRNA或蛋白表达的情况下,逆转了A1AR过表达的LLC-PK1细胞中HSP27 mRNA和蛋白的上调。FSCPX(20 μM;48小时)减弱了A1AR过表达的LLC-PK1细胞对坏死和凋亡的保护作用。[3] |
分子量 | 506.55 |
分子式 | C23H27FN4O6S |
CAS No. | 156547-56-7 |
Smiles | CCCn1c(=O)n(CCCOC(=O)c2ccc(cc2)S(F)(=O)=O)c2[nH]c(nc2c1=O)C1CCCC1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45.0 mg/mL (88.8 mM ), Sonication and heating to 60℃ are recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容